Terns Pharmaceuticals Ownership 2024 | Who Owns Terns Pharmaceuticals Now?
Institutional Ownership
89.42%
Insider Ownership
1.50%
Retail Ownership
9.08%
Institutional Holders
140.00
Terns Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10.23% | 1.03% | 7,619,135 | - | - | 51,886,309 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 8.30% | 3.89% | 6,182,992 | -475,000 | -7.13% | 42,106,176 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 8.19% | 1.24% | 6,100,000 | - | - | 41,541,000 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 6.64% | 2.97% | 4,947,738 | 4,947,738 | 100.00% | 33,694,096 | Jun 30, 2024 |
| BLACKROCK INC. | 5.53% | 0.00% | 4,120,508 | 804,979 | 24.28% | 28,060,660 | Jun 30, 2024 |
| VR ADVISER, LLC | 4.58% | 1.48% | 3,410,058 | - | - | 23,222,495 | Jun 30, 2024 |
| FMR LLC | 3.72% | 0.00% | 2,767,096 | 4,970 | 0.18% | 18,843,924 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.61% | 0.05% | 2,690,376 | 469,176 | 21.12% | 18,321,461 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.09% | 0.00% | 2,300,942 | 101,936 | 4.64% | 15,669,415 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 3.05% | 0.10% | 2,268,428 | 1,072,634 | 89.70% | 15,447,994 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 1.83% | 1.46% | 1,364,400 | 739,400 | 118.30% | 9,291,564 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 1.80% | 0.04% | 1,339,520 | -196,270 | -12.78% | 198,637,376 | Jun 30, 2024 |
| STATE STREET CORP | 1.58% | 0.00% | 1,176,833 | 271,339 | 29.97% | 8,014,233,000 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 1.54% | 1.50% | 1,149,406 | -160,569 | -12.26% | 7,827,455 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.53% | 0.00% | 1,140,392 | -2,292,400 | -66.78% | 7,766,070 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 1.51% | 0.00% | 1,122,842 | -1,259,054 | -52.86% | 7,646,554 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.51% | 0.00% | 1,121,862 | 255,941 | 29.56% | 7,640,694 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.46% | 0.07% | 1,083,905 | - | - | 7,381,393 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.31% | 0.01% | 975,000 | 125,000 | 14.71% | 6,639,750 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 1.28% | 8.21% | 956,542 | 956,542 | 100.00% | 6,514,051 | Jun 30, 2024 |
Terns Pharmaceuticals's largest institutional shareholder is ORBIMED ADVISORS LLC, holding 10.23% of the company's total share outstanding, currently valued at $51.89M. The top 10 institutional shareholders own together 56.95% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUPERSTRING CAPITAL MANAGEMENT LP | 1.28% | 8.21% | 956,542 | 956,542 | 100.00% | 6,514,051 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 8.30% | 3.89% | 6,182,992 | -475,000 | -7.13% | 42,106,176 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 6.64% | 2.97% | 4,947,738 | 4,947,738 | 100.00% | 33,694,096 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.50% | 2.12% | 369,280 | -95,799 | -20.60% | 2,514,797 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 1.54% | 1.50% | 1,149,406 | -160,569 | -12.26% | 7,827,455 | Jun 30, 2024 |
| VR ADVISER, LLC | 4.58% | 1.48% | 3,410,058 | - | - | 23,222,495 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 1.83% | 1.46% | 1,364,400 | 739,400 | 118.30% | 9,291,564 | Jun 30, 2024 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 0.83% | 1.45% | 621,643 | -76,417 | -10.95% | 92,183,440 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 8.19% | 1.24% | 6,100,000 | - | - | 41,541,000 | Jun 30, 2024 |
| ROBECO SCHWEIZ AG | 0.55% | 1.17% | 411,274 | -128,970 | -23.87% | 60,987,821 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 10.23% | 1.03% | 7,619,135 | - | - | 51,886,309 | Jun 30, 2024 |
| WORTH VENTURE PARTNERS, LLC | 0.02% | 0.88% | 17,470 | 17,470 | 100.00% | 118,971 | Jun 30, 2024 |
| BRIDGER MANAGEMENT, LLC | 0.33% | 0.86% | 246,800 | - | - | 1,680,708 | Jun 30, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 1.01% | 0.58% | 748,996 | -1,291,004 | -63.28% | 5,100,663 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.62% | 0.54% | 458,497 | 370,000 | 418.09% | 3,122,365 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.20% | 0.37% | 148,200 | - | - | 1,009,242 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.52% | 0.36% | 390,270 | 390,270 | 100.00% | 2,657,739 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 0.27% | 0.29% | 202,348 | - | - | 1,377,990 | Jun 30, 2024 |
| HARVEST FUND MANAGEMENT CO., LTD | 0.03% | 0.22% | 20,594 | 17,094 | 488.40% | 3,054,000 | Jun 30, 2024 |
| MYDA ADVISORS LLC | 0.19% | 0.21% | 140,000 | - | - | 953,400 | Jun 30, 2024 |
The largest Terns Pharmaceuticals shareholder by % of total assets is SUPERSTRING CAPITAL MANAGEMENT LP. The company owns 956.54K shares of Terns Pharmaceuticals (TERN), representing 8.21% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SOLEUS CAPITAL MANAGEMENT, L.P. | 6.64% | 2.97% | 4,947,738 | 4,947,738 | 100.00% | 33,694,096 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 3.05% | 0.10% | 2,268,428 | 1,072,634 | 89.70% | 15,447,994 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 1.28% | 8.21% | 956,542 | 956,542 | 100.00% | 6,514,051 | Jun 30, 2024 |
| BLACKROCK INC. | 5.53% | 0.00% | 4,120,508 | 804,979 | 24.28% | 28,060,660 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.00% | 0.05% | 745,044 | 745,044 | 100.00% | 5,073,750 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 1.83% | 1.46% | 1,364,400 | 739,400 | 118.30% | 9,291,564 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.00% | 0.00% | 747,442 | 587,870 | 368.40% | 5,090,080 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.94% | 0.00% | 698,714 | 491,728 | 237.57% | 4,758,242 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.61% | 0.05% | 2,690,376 | 469,176 | 21.12% | 18,321,461 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.52% | 0.36% | 390,270 | 390,270 | 100.00% | 2,657,739 | Jun 30, 2024 |
| SALEM INVESTMENT COUNSELORS INC | 0.50% | 0.08% | 371,600 | 371,600 | 100.00% | 2,530,596 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.62% | 0.54% | 458,497 | 370,000 | 418.09% | 3,122,365 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.40% | 0.00% | 298,064 | 278,854 | 1451.61% | 2,029,816 | Jun 30, 2024 |
| STATE STREET CORP | 1.58% | 0.00% | 1,176,833 | 271,339 | 29.97% | 8,014,233,000 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.71% | 0.05% | 527,417 | 270,396 | 105.20% | 78,210,667,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.51% | 0.00% | 1,121,862 | 255,941 | 29.56% | 7,640,694 | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.34% | 0.00% | 254,684 | 254,684 | 100.00% | 1,734,398 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.37% | 0.00% | 276,737 | 238,373 | 621.35% | 1,884,578 | Jun 30, 2024 |
| NEOS INVESTMENT MANAGEMENT LLC | 0.22% | 0.05% | 165,221 | 165,221 | 100.00% | 1,125,155 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.22% | 0.03% | 166,640 | 151,208 | 979.83% | 1,134,818 | Jun 30, 2024 |
As of Jun 30 2024, Terns Pharmaceuticals's largest institutional buyer is SOLEUS CAPITAL MANAGEMENT, L.P.. The company purchased 4.95M stocks of TERN, valued at $33.69M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1.53% | 0.00% | 1,140,392 | -2,292,400 | -66.78% | 7,766,070 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | - | - | - | -2,003,263 | -100.00% | - | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | - | - | - | -1,363,675 | -100.00% | - | Jun 30, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 1.01% | 0.58% | 748,996 | -1,291,004 | -63.28% | 5,100,663 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 1.51% | 0.00% | 1,122,842 | -1,259,054 | -52.86% | 7,646,554 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 8.30% | 3.89% | 6,182,992 | -475,000 | -7.13% | 42,106,176 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -450,000 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.21% | 0.00% | 153,080 | -268,557 | -63.69% | 1,042,474 | Jun 30, 2024 |
| MORGAN STANLEY | 0.45% | 0.00% | 333,618 | -253,175 | -43.15% | 2,271,939 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -250,551 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -227,821 | -100.00% | - | Jun 30, 2024 |
| MITSUBISHI UFJ TRUST & BANKING CORP | 0.14% | 0.04% | 101,783 | -218,221 | -68.19% | 15,093,401 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 1.80% | 0.04% | 1,339,520 | -196,270 | -12.78% | 198,637,376 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 1.54% | 1.50% | 1,149,406 | -160,569 | -12.26% | 7,827,455 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.03% | 0.00% | 25,985 | -160,024 | -86.03% | 176,958 | Jun 30, 2024 |
| ROBECO SCHWEIZ AG | 0.55% | 1.17% | 411,274 | -128,970 | -23.87% | 60,987,821 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.58% | 0.10% | 428,956 | -98,417 | -18.66% | 63,604,501 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.50% | 2.12% | 369,280 | -95,799 | -20.60% | 2,514,797 | Jun 30, 2024 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 0.83% | 1.45% | 621,643 | -76,417 | -10.95% | 92,183,440 | Jun 30, 2024 |
As of Jun 30 2024, Terns Pharmaceuticals's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -2.29M shares of TERN, valued at $7.77M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SOLEUS CAPITAL MANAGEMENT, L.P. | 6.64% | 2.97% | 4,947,738 | 4,947,738 | 100.00% | 33,694,096 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 1.28% | 8.21% | 956,542 | 956,542 | 100.00% | 6,514,051 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.00% | 0.05% | 745,044 | 745,044 | 100.00% | 5,073,750 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.52% | 0.36% | 390,270 | 390,270 | 100.00% | 2,657,739 | Jun 30, 2024 |
| SALEM INVESTMENT COUNSELORS INC | 0.50% | 0.08% | 371,600 | 371,600 | 100.00% | 2,530,596 | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.34% | 0.00% | 254,684 | 254,684 | 100.00% | 1,734,398 | Jun 30, 2024 |
| NEOS INVESTMENT MANAGEMENT LLC | 0.22% | 0.05% | 165,221 | 165,221 | 100.00% | 1,125,155 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.13% | 0.02% | 98,772 | 98,772 | 100.00% | 672,637 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.12% | 0.00% | 87,500 | 87,500 | 100.00% | 595,875 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.12% | 0.14% | 86,000 | 86,000 | 100.00% | 585,660 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.11% | 0.05% | 80,370 | 80,370 | 100.00% | 547,320 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.09% | 0.02% | 63,463 | 63,463 | 100.00% | 432,183 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.08% | 0.00% | 61,423 | 61,423 | 100.00% | 418,291 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.06% | 0.00% | 40,971 | 40,971 | 100.00% | 307,692 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.05% | 0.00% | 33,723 | 33,723 | 100.00% | 229,654 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 30,972 | 30,972 | 100.00% | 210,919 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.04% | 0.00% | 29,115 | 29,115 | 100.00% | 4,317,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 22,778 | 22,778 | 100.00% | 155,118 | Jun 30, 2024 |
| WORTH VENTURE PARTNERS, LLC | 0.02% | 0.88% | 17,470 | 17,470 | 100.00% | 118,971 | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | 0.02% | 0.02% | 16,503 | 16,503 | 100.00% | 112,385 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.02% | 0.02% | 16,078 | 16,078 | 100.00% | 109,491 | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.02% | 0.00% | 15,753 | 15,753 | 100.00% | 107,278 | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | 0.02% | 0.12% | 14,689 | 14,689 | 100.00% | 100,032 | Jun 30, 2024 |
| ZIMMER PARTNERS, LP | 0.02% | 0.00% | 14,042 | 14,042 | 100.00% | 95,626 | Jun 30, 2024 |
| SIMPLICITY WEALTH,LLC | 0.01% | 0.00% | 10,561 | 10,561 | 100.00% | 71,920 | Jun 30, 2024 |
| ALERA INVESTMENT ADVISORS, LLC | 0.01% | 0.01% | 10,192 | 10,192 | 100.00% | 69,408 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 2,299 | 2,299 | 100.00% | 15,656 | Jun 30, 2024 |
| PEGASUS PARTNERS LTD. | 0.00% | 0.02% | 1,589 | 1,589 | 100.00% | 235,633 | Jun 30, 2024 |
| HHM WEALTH ADVISORS, LLC | 0.00% | 0.00% | 1,400 | 1,400 | 100.00% | 9,534 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.00% | - | 1,216 | 1,216 | 100.00% | 8,281,000 | Jun 30, 2024 |
| MEEDER ASSET MANAGEMENT INC | 0.00% | 0.00% | 772 | 772 | 100.00% | 5,257 | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | 0.00% | - | 62 | 62 | 100.00% | 422 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | 0.00% | - | 40 | 40 | 100.00% | 272 | Jun 30, 2024 |
Terns Pharmaceuticals's largest new institutional shareholder by number of shares is SOLEUS CAPITAL MANAGEMENT, L.P., purchased 4.95M shares, valued at $33.69M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | - | - | - | -2,003,263 | -100.00% | - | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | - | - | - | -1,363,675 | -100.00% | - | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -450,000 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -250,551 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -227,821 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -74,755 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -71,361 | -100.00% | - | Jun 30, 2024 |
| SWISS NATIONAL BANK | - | - | - | -61,000 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -54,722 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -50,825 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -24,060 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -21,370 | -100.00% | - | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -21,206 | -100.00% | - | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | - | - | - | -17,870 | -100.00% | - | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | - | - | - | -15,466 | -100.00% | - | Jun 30, 2024 |
| PROSHARE ADVISORS LLC | - | - | - | -12,121 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,395 | -100.00% | - | Jun 30, 2024 |
| QUADRANT CAPITAL GROUP LLC | - | - | - | -1,814 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -1,400 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -327 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -17 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -9 | -100.00% | - | Jun 30, 2024 |
Terns Pharmaceuticals's largest sold out institutional shareholder by shares sold is JANUS HENDERSON GROUP PLC, sold -2.00M shares, valued at -, as of undefined.
Terns Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Transparent Value Trust | 2.58% | 41,494 | - | - | Dec 31, 2023 |
| AGF Investments Trust | 1.03% | -19,557 | - | - | Mar 31, 2024 |
| GABELLI GROWTH FUND | 1.00% | 57,000 | - | - | Dec 29, 2023 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 0.53% | 750,000 | - | - | Dec 29, 2023 |
| TETON WESTWOOD FUNDS | 0.46% | 300,000 | - | - | Dec 29, 2023 |
| SPDR S&P MIDCAP 400 ETF TRUST | 0.38% | 1,491,654 | - | - | Mar 28, 2024 |
| UBS RELATIONSHIP FUNDS | 0.34% | 79,945 | - | - | Jun 30, 2020 |
| BNY MELLON MIDCAP INDEX FUND, INC. | 0.31% | 210,690 | - | - | Apr 30, 2022 |
| DELAWARE GROUP EQUITY FUNDS I | 0.30% | 7,100 | - | - | Jan 31, 2023 |
| Clough Global Equity Fund | 0.27% | 16,500 | - | - | Jan 31, 2024 |
| ALLIED ASSET ADVISORS FUNDS | 0.23% | 2,640 | - | - | Feb 29, 2024 |
| CGM TRUST | 0.23% | 315,000 | - | - | Sep 30, 2022 |
| New Age Alpha Trust | 0.20% | 701 | - | - | May 31, 2022 |
| JP MORGAN MUTUAL FUND INVESTMENT TRUST | 0.18% | 681,064 | - | - | Dec 31, 2023 |
| Siren ETF Trust | 0.18% | 6,668 | - | - | Mar 31, 2024 |
| WANGER ADVISORS TRUST | 0.17% | 92,443 | - | - | Mar 31, 2024 |
| COLUMBIA ACORN TRUST | 0.17% | 541,096 | - | - | Mar 31, 2024 |
| BLACKROCK ENHANCED CAPITAL & INCOME FUND, INC. | 0.16% | 28,400 | - | - | Mar 31, 2024 |
| Eaton Vance Tax-Managed Buy-Write Opportunities Fund | 0.12% | 14,353 | - | - | Mar 31, 2024 |
| OSI ETF Trust | 0.09% | 16,045 | - | - | Mar 31, 2022 |
| T. Rowe Price U.S. Equity Research Fund, Inc. | 0.09% | 111,658 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.09% | 725,026 | 42,342 | 6.20% | Jan 31, 2024 |
| Clough Global Dividend & Income Fund | 0.08% | 8,900 | - | - | Jan 31, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.08% | 200,914 | - | - | Jan 31, 2024 |
| Clough Global Opportunities Fund | 0.08% | 33,300 | - | - | Jan 31, 2024 |
| Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund | 0.08% | 17,131 | - | - | Mar 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.08% | 18,993 | - | - | Dec 31, 2023 |
| Clough Funds Trust | 0.07% | 2,900 | - | - | Jan 31, 2023 |
| SCHRODER GLOBAL SERIES TRUST | 0.07% | 137 | 137 | - | Jan 31, 2021 |
| DEUTSCHE DWS INSTITUTIONAL FUNDS | 0.06% | 19,874 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.06% | 5,640 | - | - | Mar 31, 2024 |
| BLACKROCK MID-CAP VALUE SERIES, INC. | 0.06% | 73,000 | - | - | Jan 31, 2024 |
| MATTHEWS INTERNATIONAL FUNDS | 0.06% | 875,068 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 28,313 | - | - | Mar 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS 5 | 0.05% | 27,042 | - | - | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.04% | 454,600 | - | - | Jan 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.04% | 190,333 | - | - | Jan 31, 2024 |
| Guggenheim Enhanced Equity Income Fund | 0.04% | 6,990 | 479 | 7.36% | Sep 30, 2021 |
| DSS AMERICAFIRST QUANTITATIVE FUNDS | 0.04% | 904 | - | - | Dec 29, 2023 |
| Neuberger Berman Next Generation Connectivity Fund Inc. | 0.04% | 73,000 | - | - | Jan 31, 2024 |
| TAX-MANAGED GROWTH PORTFOLIO | 0.03% | 13,157 | - | - | Mar 31, 2024 |
| DELAWARE VIP TRUST | 0.03% | 121,200 | - | - | Mar 28, 2024 |
| Global Beta ETF Trust | 0.03% | 85 | - | - | May 31, 2022 |
| NEUBERGER BERMAN ADVISERS MANAGEMENT TRUST | 0.03% | 55,000 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.03% | 2,708,437 | 34,100 | 1.28% | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.03% | 234,702 | - | - | Jan 31, 2024 |
| Nuveen Core Equity Alpha Fund | 0.03% | 1,910 | - | - | Mar 31, 2024 |
| TETON WESTWOOD FUNDS | 0.02% | 15,506 | - | - | Dec 29, 2023 |
| FIDELITY DESTINY PORTFOLIOS | 0.02% | 45,000 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.02% | 251,088 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES I | 0.02% | 7,133 | - | - | Mar 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.02% | 150,000 | - | - | Feb 29, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 81,480 | -4,770 | -5.53% | Mar 31, 2020 |
| Collaborative Investment Series Trust | 0.01% | 1,998 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 76,560 | -6,809 | -8.17% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.01% | 246,900 | - | - | Mar 31, 2024 |
| Northern Lights Variable Trust | 0.01% | 11,238 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 6,651 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.01% | 24,000 | - | - | Mar 28, 2024 |
| WESMARK FUNDS | 0.01% | 32,636 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 21,596 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.01% | 200 | - | - | Dec 31, 2023 |
| ETFis Series Trust I | 0.01% | 12,664 | 4,260 | 50.69% | Jan 31, 2024 |
| Absolute Shares Trust | 0.01% | 3,382 | - | - | Mar 31, 2024 |
| GLENMEDE FUND INC | 0.01% | 76,840 | - | - | Jan 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 76,878 | - | - | Mar 28, 2024 |
| FIRST INVESTORS EQUITY FUNDS | 0.01% | 39,500 | 39,500 | - | Sep 30, 2019 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.01% | 21,987 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.01% | 57,200 | - | - | Mar 31, 2024 |
| FIDELITY PURITAN TRUST | 0.01% | 366,835 | - | - | Jan 31, 2024 |
| AQUILA FUNDS TRUST | 0.01% | 6,362 | - | - | Mar 28, 2024 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.01% | 3,071 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,158 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 33,887 | 33,887 | - | Aug 31, 2023 |
| Nushares ETF Trust | 0.01% | 37,091 | 37,091 | - | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS V | 0.01% | 296,800 | - | - | Feb 29, 2024 |
| MASTER LARGE CAP SERIES LLC | 0.00% | 4,395 | 4,395 | - | Mar 31, 2022 |
| Fidelity Commonwealth Trust II | 0.00% | 32,416 | - | - | Aug 31, 2023 |
| FIDELITY ADVISOR SERIES I | 0.00% | 837,786 | - | - | Feb 29, 2024 |
| NUVEEN INVESTMENT TRUST | 0.00% | 2,359 | - | - | Mar 31, 2024 |
| FIDELITY CONTRAFUND | 0.00% | 274,119 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,752,530 | -530,576 | -23.24% | Mar 31, 2024 |
| TrimTabs ETF Trust | 0.00% | 2,709 | - | - | Jan 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 3,400 | - | - | Dec 31, 2023 |
| M FUND INC | 0.00% | 1,900 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 226,996 | - | - | Feb 29, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 150,818 | - | - | Mar 31, 2024 |
| Bernstein Fund Inc | 0.00% | 30,110 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 43,138 | - | - | Feb 29, 2024 |
| FIRST INVESTORS LIFE SERIES FUNDS | 0.00% | 10,100 | 10,100 | - | Sep 30, 2019 |
| MSS Series Trust | 0.00% | 246 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 114,609 | - | - | Jan 31, 2024 |
| AMG FUNDS III | 0.00% | 14,146 | - | - | Mar 28, 2024 |
| Franklin Custodian Funds | 0.00% | 1,300,000 | - | - | Mar 31, 2024 |
| TOUCHSTONE STRATEGIC TRUST | 0.00% | 156,152 | - | - | Mar 31, 2024 |
| PUTNAM CONVERTIBLE SECURITIES FUND | 0.00% | 11,620 | - | - | Jan 31, 2024 |
| ARCHER INVESTMENT SERIES TRUST | 0.00% | 631 | - | - | Feb 29, 2024 |
| Virtus Artificial Intelligence & Technology Opportunities Fund | 0.00% | 8,010 | - | - | Jan 31, 2024 |
| Virtus Investment Trust | 0.00% | 65,970 | - | - | Mar 28, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 33,500 | -387 | -1.14% | Mar 31, 2024 |
Terns Pharmaceuticals's largest mutual fund holder by % of total assets is "Transparent Value Trust", owning 41.49K shares, compromising 2.58% of its total assets.
Terns Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 140 | 19.66% |
| 31 Mar, 24 | 117 | 6.36% |
| 31 Dec, 23 | 110 | 12.24% |
| 30 Sep, 23 | 98 | -11.71% |
| 30 Jun, 23 | 111 | 40.51% |
| 31 Mar, 23 | 79 | 21.54% |
| 31 Dec, 22 | 65 | 44.44% |
| 30 Sep, 22 | 45 | 18.42% |
| 30 Jun, 22 | 38 | -11.63% |
| 31 Mar, 22 | 43 | 16.22% |
| 31 Dec, 21 | 37 | 12.12% |
| 30 Sep, 21 | 33 | -8.33% |
| 30 Jun, 21 | 36 | -14.29% |
| 31 Mar, 21 | 42 | - |
As of 30 Jun 24, 140 institutions are holding Terns Pharmaceuticals's shares, representing an increase of 19.66% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 66,584,833 | 5.52% |
| 31 Mar, 24 | 63,102,304 | -0.76% |
| 31 Dec, 23 | 63,584,999 | 3.76% |
| 30 Sep, 23 | 61,282,363 | 6.18% |
| 30 Jun, 23 | 57,716,068 | 8.43% |
| 31 Mar, 23 | 53,226,532 | 7.04% |
| 31 Dec, 22 | 49,723,797 | 64.16% |
| 30 Sep, 22 | 30,289,272 | 105.74% |
| 30 Jun, 22 | 14,722,431 | -12.56% |
| 31 Mar, 22 | 16,836,442 | 2.02% |
| 31 Dec, 21 | 16,503,423 | -1.33% |
| 30 Sep, 21 | 16,725,072 | 0.62% |
| 30 Jun, 21 | 16,621,277 | -7.17% |
| 31 Mar, 21 | 17,905,568 | - |
Terns Pharmaceuticals (TERN) has 66.58M shares outstanding as of 30 Jun 24, up 5.52% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 89.42% | 1.24% |
| 31 Mar, 24 | 84.82% | 1.10% |
| 31 Dec, 23 | 87.91% | 1.20% |
| 30 Sep, 23 | 85.67% | 1.31% |
| 30 Jun, 23 | 80.88% | 1.39% |
| 31 Mar, 23 | 76.28% | 0.92% |
| 31 Dec, 22 | 90.91% | 1.47% |
| 30 Sep, 22 | 78.65% | 2.32% |
| 30 Jun, 22 | 58.18% | 1.31% |
| 31 Mar, 22 | 66.63% | 1.56% |
| 31 Dec, 21 | 65.31% | 1.48% |
| 30 Sep, 21 | 66.51% | 1.52% |
| 30 Jun, 21 | 66.19% | 0.47% |
| 31 Mar, 21 | 118.11% | - |
As of 30 Jun 24, Terns Pharmaceuticals is held by 89.42% institutional shareholders, representing a 1.24% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 95 | 48.44% |
| 31 Mar, 24 | 64 | 4.92% |
| 31 Dec, 23 | 61 | 48.78% |
| 30 Sep, 23 | 41 | -41.43% |
| 30 Jun, 23 | 70 | 29.63% |
| 31 Mar, 23 | 54 | 12.50% |
| 31 Dec, 22 | 48 | 41.18% |
| 30 Sep, 22 | 34 | 54.55% |
| 30 Jun, 22 | 22 | 22.22% |
| 31 Mar, 22 | 18 | -18.18% |
| 31 Dec, 21 | 22 | 15.79% |
| 30 Sep, 21 | 19 | 11.76% |
| 30 Jun, 21 | 17 | -59.52% |
| 31 Mar, 21 | 42 | - |
95 institutional shareholders have increased their position in TERN stock as of 30 Jun 24 compared to 64 in the previous quarter (a 48.44% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 23 | -28.13% |
| 31 Mar, 24 | 32 | 39.13% |
| 31 Dec, 23 | 23 | -36.11% |
| 30 Sep, 23 | 36 | 56.52% |
| 30 Jun, 23 | 23 | 53.33% |
| 31 Mar, 23 | 15 | 7.14% |
| 31 Dec, 22 | 14 | 75.00% |
| 30 Sep, 22 | 8 | -27.27% |
| 30 Jun, 22 | 11 | -21.43% |
| 31 Mar, 22 | 14 | 133.33% |
| 31 Dec, 21 | 6 | -14.29% |
| 30 Sep, 21 | 7 | -36.36% |
| 30 Jun, 21 | 11 | - |
| 31 Mar, 21 | - | - |
23 institutional shareholders have reduced their position in TERN stock as of 30 Jun 24 compared to 32 in the previous quarter (a -28.13% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 140 | 19.66% | 66,584,833 | 5.52% | 89.42% | 1.24% | 95 | 48.44% | 23 | -28.13% |
| 31 Mar, 24 | 117 | 6.36% | 63,102,304 | -0.76% | 84.82% | 1.10% | 64 | 4.92% | 32 | 39.13% |
| 31 Dec, 23 | 110 | 12.24% | 63,584,999 | 3.76% | 87.91% | 1.20% | 61 | 48.78% | 23 | -36.11% |
| 30 Sep, 23 | 98 | -11.71% | 61,282,363 | 6.18% | 85.67% | 1.31% | 41 | -41.43% | 36 | 56.52% |
| 30 Jun, 23 | 111 | 40.51% | 57,716,068 | 8.43% | 80.88% | 1.39% | 70 | 29.63% | 23 | 53.33% |
| 31 Mar, 23 | 79 | 21.54% | 53,226,532 | 7.04% | 76.28% | 0.92% | 54 | 12.50% | 15 | 7.14% |
| 31 Dec, 22 | 65 | 44.44% | 49,723,797 | 64.16% | 90.91% | 1.47% | 48 | 41.18% | 14 | 75.00% |
| 30 Sep, 22 | 45 | 18.42% | 30,289,272 | 105.74% | 78.65% | 2.32% | 34 | 54.55% | 8 | -27.27% |
| 30 Jun, 22 | 38 | -11.63% | 14,722,431 | -12.56% | 58.18% | 1.31% | 22 | 22.22% | 11 | -21.43% |
| 31 Mar, 22 | 43 | 16.22% | 16,836,442 | 2.02% | 66.63% | 1.56% | 18 | -18.18% | 14 | 133.33% |
| 31 Dec, 21 | 37 | 12.12% | 16,503,423 | -1.33% | 65.31% | 1.48% | 22 | 15.79% | 6 | -14.29% |
| 30 Sep, 21 | 33 | -8.33% | 16,725,072 | 0.62% | 66.51% | 1.52% | 19 | 11.76% | 7 | -36.36% |
| 30 Jun, 21 | 36 | -14.29% | 16,621,277 | -7.17% | 66.19% | 0.47% | 17 | -59.52% | 11 | - |
| 31 Mar, 21 | 42 | - | 17,905,568 | - | 118.11% | - | 42 | - | - | - |
Terns Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Terns Pharmaceuticals's stock was made by Quigley Jill M. on Aug 05 2024, selling 6,143 shares at $7.68 per share (valued at $47.15K).
Terns Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 8 | 16 | 50.00% |
| Q2 2024 | 10 | 9 | 111.11% |
| Q1 2024 | 9 | 3 | 300.00% |
| Q4 2023 | 3 | - | - |
| Q2 2023 | 10 | - | - |
| Q1 2023 | 4 | - | - |
| Q4 2022 | 7 | 3 | 233.33% |
| Q3 2022 | 24 | - | - |
| Q2 2022 | 12 | - | - |
| Q1 2022 | 4 | - | - |
| Q3 2021 | 8 | - | - |
| Q1 2021 | 21 | 27 | 77.78% |
| Q1 2020 | - | - | - |
| Q3 2005 | 1 | - | - |
| Q4 2004 | 3 | - | - |
| Q3 2004 | 2 | - | - |
| Q4 2003 | 3 | 7 | 42.86% |
| Q2 2003 | 5 | - | - |
| Q3 2001 | 1 | - | - |
| Q2 2001 | 1 | - | - |
8 total buy trades, and 16 total sell trades (buy/sell ratio of 0.50%) were made by Terns Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 14 | - |
| Q2 2024 | 2 | 9 | 22.22% |
| Q1 2024 | - | - | - |
| Q4 2023 | 2 | - | - |
| Q2 2023 | 3 | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 7 | 3 | 233.33% |
| Q3 2022 | 22 | - | - |
| Q2 2022 | 3 | - | - |
| Q1 2022 | - | - | - |
| Q3 2021 | - | - | - |
| Q1 2021 | 8 | - | - |
| Q1 2020 | - | - | - |
| Q3 2005 | - | - | - |
| Q4 2004 | - | - | - |
| Q3 2004 | - | - | - |
| Q4 2003 | - | 3 | - |
| Q2 2003 | - | - | - |
| Q3 2001 | - | - | - |
| Q2 2001 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 14 open market sell trades of Terns Pharmaceuticals's stocks.
Terns Pharmaceuticals Peer Ownership
TERN Ownership FAQ
Who Owns Terns Pharmaceuticals?
Terns Pharmaceuticals is owned by institutional shareholders (89.42%), insiders (1.50%), and public (9.08%). The largest institutional shareholder of Terns Pharmaceuticals is ORBIMED ADVISORS LLC (10.23% of total shares) and the top mutual fund owner is Transparent Value Trust (2.58% of total shares).
Who are the major institutional shareholders of Terns Pharmaceuticals?
Terns Pharmaceuticals's major institutional shareholders are ORBIMED ADVISORS LLC, VIVO CAPITAL, LLC, DEEP TRACK CAPITAL, LP, SOLEUS CAPITAL MANAGEMENT, L.P., and BLACKROCK INC.. The top five shareholders own together 38.91% of the company's share outstanding.
How many Terns Pharmaceuticals shareholders are there?
As of Jun 2024, there are 140 institutional shareholders of Terns Pharmaceuticals.
What percentage of Terns Pharmaceuticals is owned by ORBIMED ADVISORS LLC?
ORBIMED ADVISORS LLC owns 7.62M shares of Terns Pharmaceuticals, representing 10.23% of the company's total shares outstanding, valued at $51.89M (as of Jun 2024).
What percentage of Terns Pharmaceuticals is owned by VIVO CAPITAL, LLC?
As of Jun 2024, VIVO CAPITAL, LLC holds 6.18M shares of Terns Pharmaceuticals (TERN), compromising 8.30% of the company, valued at $42.11M.
What percentage of Terns Pharmaceuticals is owned by DEEP TRACK CAPITAL, LP?
DEEP TRACK CAPITAL, LP is the third largest holder of Terns Pharmaceuticals. The company owns 6.1M of the company's shares outstanding (worth $41.54M).